229 related articles for article (PubMed ID: 29994978)
1. Outcomes of Pancreas Transplant Recipients With De Novo Donor-specific Antibodies.
Parajuli S; Alagusundaramoorthy S; Aziz F; Garg N; Redfield RR; Sollinger H; Kaufman D; Djamali A; Odorico J; Mandelbrot D
Transplantation; 2019 Feb; 103(2):435-440. PubMed ID: 29994978
[TBL] [Abstract][Full Text] [Related]
2. Early immunosuppression treatment correlates with later de novo donor-specific antibody development after kidney and pancreas transplantation.
Pelletier RP; Rajab AA; Diez A; DiPaola NR; Bumgardner GL; Elkhammas EA; Henry ML
Clin Transplant; 2015 Dec; 29(12):1119-27. PubMed ID: 26382932
[TBL] [Abstract][Full Text] [Related]
3. The Utility of Donor-specific Antibody Monitoring and the Role of Kidney Biopsy in Simultaneous Liver and Kidney Recipients With De Novo Donor-specific Antibodies.
Parajuli S; Aziz F; Blazel J; Muth BL; Garg N; Mohamed M; Rice J; Mezrich JD; Hidalgo LG; Mandelbrot D
Transplantation; 2021 Jul; 105(7):1548-1555. PubMed ID: 32732618
[TBL] [Abstract][Full Text] [Related]
4. Role of de novo donor-specific anti-HLA antibodies in kidney graft failure: A case-control study.
Castro A; Malheiro J; Tafulo S; Dias L; Martins LS; Fonseca I; Beirão I; Castro-Henriques A; Cabrita A
HLA; 2017 Nov; 90(5):267-275. PubMed ID: 28776960
[TBL] [Abstract][Full Text] [Related]
5. Early clearance vs persistence of de novo donor-specific antibodies following lung transplantation.
Islam AK; Sinha N; DeVos JM; Kaleekal TS; Jyothula SS; Teeter LD; Nguyen DTM; Eagar TN; Moore LW; Puppala M; Wong STC; Knight RJ; Frost AE; Graviss EA; Osama Gaber A
Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28658512
[TBL] [Abstract][Full Text] [Related]
6. Clinical Outcome of Patients With De Novo C1q-Binding Donor-Specific HLA Antibodies After Renal Transplantation.
Bamoulid J; Roodenburg A; Staeck O; Wu K; Rudolph B; Brakemeier S; Halleck F; Lehner L; Schönemann C; Lachmann N; Budde K
Transplantation; 2017 Sep; 101(9):2165-2174. PubMed ID: 27653301
[TBL] [Abstract][Full Text] [Related]
7. De novo donor-specific HLA antibodies: biomarkers of pancreas transplant failure.
Mittal S; Page SL; Friend PJ; Sharples EJ; Fuggle SV
Am J Transplant; 2014 Jul; 14(7):1664-71. PubMed ID: 24866735
[TBL] [Abstract][Full Text] [Related]
8. The association between human leukocyte antigen eplet mismatches, de novo donor-specific antibodies, and the risk of acute rejection in pediatric kidney transplant recipients.
Sharma A; Taverniti A; Graf N; Teixeira-Pinto A; Lewis JR; Lim WH; Alexander SI; Durkan A; Craig JC; Wong G
Pediatr Nephrol; 2020 Jun; 35(6):1061-1068. PubMed ID: 32065279
[TBL] [Abstract][Full Text] [Related]
9. Results of early treatment for de novo donor-specific antibodies in pediatric kidney transplant recipients in a cross-sectional and longitudinal cohort.
Charnaya O; Tuchman S; Moudgil A
Pediatr Transplant; 2018 Mar; 22(2):. PubMed ID: 29356221
[TBL] [Abstract][Full Text] [Related]
10. De novo DQ donor-specific antibodies are associated with worse outcomes compared to non-DQ de novo donor-specific antibodies following heart transplantation.
Cole RT; Gandhi J; Bray RA; Gebel HM; Morris A; McCue A; Yin M; Laskar SR; Book W; Jokhadar M; Smith A; Nguyen D; Vega JD; Gupta D
Clin Transplant; 2017 Apr; 31(4):. PubMed ID: 28181305
[TBL] [Abstract][Full Text] [Related]
11. Incidence and impact of de novo donor-specific alloantibody in primary renal allografts.
Everly MJ; Rebellato LM; Haisch CE; Ozawa M; Parker K; Briley KP; Catrou PG; Bolin P; Kendrick WT; Kendrick SA; Harland RC; Terasaki PI
Transplantation; 2013 Feb; 95(3):410-7. PubMed ID: 23380861
[TBL] [Abstract][Full Text] [Related]
12. Utility of protocol kidney biopsies for de novo donor-specific antibodies.
Parajuli S; Reville PK; Ellis TM; Djamali A; Mandelbrot DA
Am J Transplant; 2017 Dec; 17(12):3210-3218. PubMed ID: 28805293
[TBL] [Abstract][Full Text] [Related]
13. The detrimental impact of persistent vs an isolated occurrence of de novo donor-specific antibodies on intermediate-term renal transplant outcomes.
Loucks-DeVos JM; Eagar TN; Gaber AO; Patel SJ; Teeter LD; Graviss EA; Knight RJ
Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28582797
[TBL] [Abstract][Full Text] [Related]
14. Impact of HLA Eplet Mismatch on De Novo Donor Specific Antibody Formation After Kidney Transplantation.
Yanyiam P; Kantachuvesiri S; Thammanichanond D
Transplant Proc; 2024 Apr; 56(3):515-520. PubMed ID: 38368130
[TBL] [Abstract][Full Text] [Related]
15. Clinical impact of complement (C1q, C3d) binding De Novo donor-specific HLA antibody in kidney transplant recipients.
Lee H; Han E; Choi AR; Ban TH; Chung BH; Yang CW; Choi YJ; Oh EJ
PLoS One; 2018; 13(11):e0207434. PubMed ID: 30427941
[TBL] [Abstract][Full Text] [Related]
16. Analysis of predictive and preventive factors for de novo DSA in kidney transplant recipients.
Hirai T; Furusawa M; Omoto K; Ishida H; Tanabe K
Transplantation; 2014 Aug; 98(4):443-50. PubMed ID: 24717219
[TBL] [Abstract][Full Text] [Related]
17. Eplet mismatch scores and de novo donor-specific antibody development in simultaneous pancreas-kidney transplantation.
Ladowski JM; Mullins H; Romine M; Kloda D; Young C; Hauptfeld-Dolejsek V; Houp J; Locke J
Hum Immunol; 2021 Mar; 82(3):139-146. PubMed ID: 33390268
[TBL] [Abstract][Full Text] [Related]
18. De Novo DQ Donor-Specific Antibodies Are Associated with Chronic Lung Allograft Dysfunction after Lung Transplantation.
Tikkanen JM; Singer LG; Kim SJ; Li Y; Binnie M; Chaparro C; Chow CW; Martinu T; Azad S; Keshavjee S; Tinckam K
Am J Respir Crit Care Med; 2016 Sep; 194(5):596-606. PubMed ID: 26967790
[TBL] [Abstract][Full Text] [Related]
19. Donor-specific Antibody Surveillance and Graft Outcomes in Pediatric Kidney Transplant Recipients.
Engen RM; Park GE; Schumacher CS; Gimferrer I; Warner P; Finn LS; Weiss NS; Smith JM
Transplantation; 2018 Dec; 102(12):2072-2079. PubMed ID: 29863579
[TBL] [Abstract][Full Text] [Related]
20. Impact of Anti-HLA De Novo Donor Specific Antibody on Graft Outcomes in Pancreas Transplantation: A Meta-Analysis.
Khan SM; Sumbal R; Schenk AD
Transplant Proc; 2021 Dec; 53(10):3022-3029. PubMed ID: 34772490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
